SNY - In Heart Burn Drug Zantac's Litigation Saga Sanofi Nears Settlement in Major Lawsuit Cluster | Benzinga
Sanofi SA (NASDAQ:SASY) has announced an agreement in principle to settle approximately 4,000 lawsuits in the United States linked to the discontinued heartburn drug Zantac.
The company stated that the settlement encompasses many pending cases across various U.S. state courts, excluding Delaware. The financial terms remain confidential.
The settlement arises amidst allegations that Zantac, manufactured by Sanofi and other companies, may have caused cancer due to the presence of NDMA, a possible carcinogen found in the drug.
Sanofi clarified that they have not admitted any liability while settling these cases, maintaining their stance against the claims.
The company emphasized its ...